KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Net Margin (2016 - 2025)

Gilead Sciences' Net Margin history spans 17 years, with the latest figure at 31.9% for Q4 2025.

  • For Q4 2025, Net Margin rose 836.0% year-over-year to 31.9%; the TTM value through Dec 2025 reached 30.08%, up 2841.0%, while the annual FY2025 figure was 28.9%, 2724.0% up from the prior year.
  • Net Margin reached 31.9% in Q4 2025 per GILD's latest filing, down from 39.28% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 39.28% in Q3 2025 to a low of 62.38% in Q1 2024.
  • Average Net Margin over 5 years is 17.91%, with a median of 22.66% recorded in 2022.
  • Peak YoY movement for Net Margin: skyrocketed 9158bps in 2021, then crashed -7788bps in 2024.
  • A 5-year view of Net Margin shows it stood at 5.19% in 2021, then soared by 326bps to 22.1% in 2022, then decreased by -10bps to 19.9% in 2023, then grew by 18bps to 23.54% in 2024, then skyrocketed by 35bps to 31.9% in 2025.
  • Per Business Quant, the three most recent readings for GILD's Net Margin are 31.9% (Q4 2025), 39.28% (Q3 2025), and 27.69% (Q2 2025).